Download by
Scanning QR Code
No Stock Yet
No Data
Amgen Inc. Stock Rises Wednesday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Amgen Inc. AMGN inched 0.79% higher to $245.43 Wednesday, on what proved to be an all-aroun
ReCode Therapeutics raises $120M in round co-led by Bayer, with participation from Amgen
Genetic medicines company ReCode Therapeutics has got $120M in an extended financing round led by new investors including an investment unit of Bayer (OTCPK:BAYRY) (OTCPK:BAYZF). AyurMaya, an affiliat
Can-Fite stock rises 23% as psoriasis drug beats placebo but lags behind Otezla in phase 3 trial
Can-Fite BioPharma's (NYSE:CANF) oral drug piclidenoson helped reduce severity of symptoms compared to placebo, but failed to beat Amgen's (AMGN) Otezla in adult patients with moderate to severe plaqu
Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial
Can-Fite BioPharma Ltd (NYSE:CANF) announced topline results from the COMFORT Phase 3 trial of Piclidenoson in more than 400 adults with moderate to severe plaque psoriasis.The study data show that pa
Amgen to sell Turkish unit Gensenta for $135M
Amgen (NASDAQ:AMGN) has reached an agreement with Turkish pharmaceutical company Eczacıbaşı Group to sell 99.96% stake in its Istanbul-based unit Gensenta for $135M, Daily Sabah reported Wednesday. Fo
688181.SH plans to invest 50 million yuan in Shouxin Jinan.
Zhitong Financial APP News, 800 million time and Space (688181.SH) issued an announcement that in order to broaden investment methods and channels, grasp investment opportunities in the field of new materials, and optimize the company's investment structure with the help of the experience and resources of professional investment institutions, the company plans to invest in Shouxin Jinan as a limited partner with its own capital of RMB 50 million. The company's capital contribution accounts for 2.41% of the total capital subscribed to the first NJA after the completion of this round. The specific circumstances shall be subject to the legal documents such as the Partnership Agreement finally signed. Shouxin Jinan focuses on the advanced electrical steel materials, cast superalloys and fine materials of Shougang Group.
Global Peptide Therapeutics Markets Report 2022-2028 Featuring Teva Pharma, Takeda Pharma, Sanofi, Pfizer, Novartis, GlaxoSmithKline, Hoffmann-La Roche, Eli Lilly and Co, Bachem, & Amgen
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering. The report predicts the global peptide
Amgen Inc. Stock Outperforms Market Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Amgen Inc. AMGN dropped 0.21% to $244.85 Monday, on what proved to be an all-around poor tr
Amgen put volume heavy and directionally bearish
Bearish flow noted in Amgen with 2,487 puts trading, or 1.5x expected. Most active are Jul-22 225 puts and Jul-22 255 calls, with total volume in those strikes near 2,100 contracts. The Put/Call Ratio
Peering Into Amgen's Recent Short Interest
Amgen's (NASDAQ:AMGN) short percent of float has risen 7.63% since its last report. The company recently reported that it has 20.30 million shares sold short, which is 3.81% of all regular shares that
Loading...
No Stock Yet